Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib + Chemotherapy in Ph+ ALL
NCT00720109Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2008
- Primary completion
- Dec 2014
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of dasatinib in Acute lymphoblastic leukemia, Philadelphia chromosome positive, sponsored by National Cancer Institute. Started Jul 2008; status: completed.
02
Drugs
dasatinib
03
Conditions
Acute lymphoblastic leukemia, Philadelphia chromosome positive
Beyond the preview
Go deeper on NCT00720109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720109.